NTLA and CRSP Related Headlines
Go Back- Cutting DNA, Cutting Edge: Companies Using CRISPR and Other Gene Editing Technologies to Rewrite the Future of Industry and Medicine
- FDA Clears Way for Faster Personalized Gene Editing Treatments
- Intellia stock tumbles after pausing gene therapy trials on safety concerns
- Sam Altman Brain Chip Venture Is Mulling Gene Therapy Approach - Bloomberg
- CRISPR Therapeutics (CRSP) gains on continued chatter
- Verve Therapeutics takeover has 'positive readthrough' for gene editing space - BMO Capital
